News Incyte Corporation

Equities

INCY

US45337C1027

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
57.79 ^USD	+0.86%		+0.84%	-7.96%

May. 23	Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	MT
May. 21	Incyte Acquires 2 Office Buildings in Delaware	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Incyte Completes Acquisition of Escient Pharmaceuticals	May. 30	BU
Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	May. 23	MT
Incyte Acquires 2 Office Buildings in Delaware	May. 21	MT
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings	May. 21	BU
Incyte to Present at Upcoming Investor Conference	May. 21	BU
Transcript : Incyte Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM	May. 15
Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress	May. 14	BU
Equities Close Mixed as Markets Weigh Consumer Inflation Survey	May. 13	MT
Equities Close Mixed as Markets Parse Consumer Inflation Survey	May. 13	MT
Incyte, Squarespace rise; Chimera Investment, Amazon fall, Monday, 5/13/2024	May. 13	AQ
Equities Mixed Intraday as Markets Analyze Consumer Inflation Survey	May. 13	MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading	May. 13	MT
Increasing Short-Term Inflation Expectations Weigh on US Equity Indexes Ahead of Consumer, Producer Prices	May. 13	MT
US Equity Indexes Trade Mixed as Short-Term Inflation Expectations Increase	May. 13	MT
Incyte Corporation announces an Equity Buyback for $1,672 million worth of its shares.	May. 13	CI
Sector Update: Health Care Stocks Decline Pre-Bell Monday	May. 13	MT
Incyte Launches $1.67 Billion Share Repurchase 'Dutch Auction' Tender Offer; to Buy Back $328 Million of Baker Entities' Shares	May. 13	MT
Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock	May. 13	BU
Incyte Corporation authorizes a Buyback Plan.	May. 12	CI
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	May. 07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Incyte Corporation : Is a big change imminent?

October 26, 2023 at 10:00 am EDT